Target intelligence / Profile preview

Neisseria meningitidis Capsular Polysaccharides (CPS)

Target
CPS
Molecular classification
Polysaccharide, Capsular polysaccharide
01

Overview

Neisseria meningitidis capsular polysaccharides are complex carbohydrate structures that form a capsule surrounding the bacterium. This capsule is the primary virulence determinant of N. meningitidis, enabling it to evade host immune responses and cause invasive diseases such as septicemia and meningitis. The presence or absence, as well as the specific structure of these polysaccharides, forms the basis for classifying N. meningitidis into serogroups. Antibodies targeting these capsular polysaccharides are central to protective immunity against invasive disease; thus, they are key components in vaccine development (except for serogroup B).

Other names
Meningococcal Capsular PolysaccharideN. meningitidis CPSSerogroup-specific polysaccharideGroup A capsular polysaccharideGroup B capsular polysaccharideGroup C capsular polysaccharideGroup Y capsular polysaccharideGroup W capsular polysaccharide
02

Mechanism of action

Antibodies bind to the capsular polysaccharide, promoting opsonization and complement-mediated killing of the bacteria; vaccines induce the production of such antibodies.

03

Biological functions

Immune evasionProtection from phagocytosisComplement inhibitionVirulenceBacterial survivalAdhesion Inhibition
04

Disease associations

MeningitisSepticemiaInvasive Meningococcal DiseaseInfection
05

Safety considerations

Poor immunogenicity of serogroup B polysaccharideCapsule switching leading to vaccine escapePotential for autoimmune cross-reactivity (e.g., with serogroup B)Limited efficacy in infants for some serogroups
06

Interacting drugs

Anti-capsular polysaccharide antibodies

2 more in the full profile.

07

Biomarkers

Capsular polysaccharide serogroup identification in CSF or bloodAntibody titers against specific capsular serogroups (vaccine response)Detection of N. meningitidis DNA by PCR

Beyond the preview

Go deeper on Neisseria meningitidis Capsular Polysaccharides (CPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neisseria meningitidis Capsular Polysaccharides (CPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call